NCT04950075Phase 2Active not recruiting

Study of INBRX-109 in Conventional Chondrosarcoma

Study sponsor: Inhibrx Biosciences, Inc · INBX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-09-30Actual
Enrollment · participants206Actual
Source updated2026-07-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 201 participants (planned). After: 206 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2025. After: 30 Sep 2025.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview